← Leaderboards
Yoshihiro Kawaoka
University Of Wisconsin Madison
$60,396,743
Attributed
$60,506,806
Total exposure
27
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$98,239,272 · 29
By mechanism
U19$40,118,763 · 5
P01$23,236,986 · 4
R01$22,282,079 · 8
U54$5,368,748 · 3
U01$2,985,700 · 1
R21$1,835,182 · 4
Top collaborators
- Pamuk Bilsel1 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- David J Miller$7,086,459
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusInfectionProteinsMutantImmune ResponseBaseVirus DiseasesPathogenicityCellsResponseVaccinesViralResearch Project GrantsAffectEbola VirusNational Institute Of Allergy And Infectious DiseaseAnimalsInfluenzavirusGenesInfluenza A VirusProgramsInfluenzaVirulenceLead
Grant awards (111)
Development of broadly-protective vaccines for influenza B viruses$495,150
R33 · FY2025 · AI · contact PI
Development of broadly-protective vaccines for influenza B viruses$522,900
R33 · FY2024 · AI · contact PI
PanCorVac (Center for Pan-Coronavirus Vaccine Development)$4,618,169
P01 · FY2023 · AI · contact PI
Design and evaluation of pan-CoV vaccines$2,819,456
P01 · FY2023 · AI · contact PI
Immunological responses to pan-CoV vaccines$1,558,161
P01 · FY2023 · AI · contact PI
Syrian hamsters as an animal model for influenza virus research$751,841
R01 · FY2023 · AI · contact PI
Development of broadly-protective vaccines for influenza B viruses$457,843
R33 · FY2023 · AI · contact PI
Administrative core$240,552
P01 · FY2023 · AI · contact PI
Syrian hamsters as an animal model for influenza virus research$754,269
R01 · FY2022 · AI · contact PI
COVID-19 comorbidity studies in Syrian hamster models$233,250
R21 · FY2022 · AI · contact PI
Development of broadly-protective vaccines for influenza B viruses$196,944
R21 · FY2022 · AI · contact PI
PanCorVac (Center for Pan-Coronavirus Vaccine Development)$7,000,324
P01 · FY2021 · AI · contact PI
Design and evaluation of pan-CoV vaccines$4,242,156
P01 · FY2021 · AI · contact PI
Immunological responses to pan-CoV vaccines$2,408,043
P01 · FY2021 · AI · contact PI
Syrian hamsters as an animal model for influenza virus research$771,313
R01 · FY2021 · AI · contact PI
Administrative core$350,125
P01 · FY2021 · AI · contact PI
Development of broadly-protective vaccines for influenza B viruses$227,774
R21 · FY2021 · AI · contact PI
COVID-19 comorbidity studies in Syrian hamster models$194,375
R21 · FY2021 · AI · contact PI
A Transgenic Mouse Model to Study Ebolaviruses and other Filoviruses$194,271
R21 · FY2021 · AI · contact PI
Syrian hamsters as an animal model for influenza virus research$721,773
R01 · FY2020 · AI · contact PI
A Transgenic Mouse Model to Study Ebolaviruses and other Filoviruses$206,568
R21 · FY2020 · AI · contact PI
Modeling Host Responses to Understand Severe Human Virus Infections$5,024,020
U19 · FY2017 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$1,663,821
U19 · FY2017 · AI · contact PI
Administrative Core$515,250
U19 · FY2017 · AI · contact PI
Determining the functions of novel genes for influenza A and Ebola viruses$330,256
U19 · FY2017 · AI · contact PI
Modeling Host Responses to Understand Severe Human Virus Infections$6,428,344
U19 · FY2016 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$2,904,054
U19 · FY2016 · AI · contact PI
Transmissibility of avian influenza viruses in mammals$605,206
R01 · FY2016 · AI · contact PI
Determining the functions of novel genes for influenza A and Ebola viruses$376,912
U19 · FY2016 · AI · contact PI
Administrative Core$341,969
U19 · FY2016 · AI · contact PI
Host Responses to Zika Virus Infections in Rhesus Macaques$133,333
U19 · FY2016 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$133,333
U19 · FY2016 · AI · contact PI
Modeling Host Responses to Understand Severe Human Virus Infections$4,673,565
U19 · FY2015 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$1,097,974
U19 · FY2015 · AI · contact PI
Modeling Host Responses to Understand Severe Human Virus Infections$881,381
U19 · FY2015 · AI · contact PI
Administrative Core$748,106
U19 · FY2015 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$728,987
U19 · FY2015 · AI · contact PI
Transmissibility of avian influenza viruses in mammals$677,974
R01 · FY2015 · AI · contact PI
Determining the functions of novel genes for influenza A and Ebola viruses$594,996
U19 · FY2015 · AI · contact PI
Modeling Host Responses to Understand Severe Human Virus Infections$4,865,656
U19 · FY2014 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$1,276,716
U19 · FY2014 · AI · contact PI
Administrative Core$981,320
U19 · FY2014 · AI · contact PI
Transmissibility of avian influenza viruses in mammals$611,416
R01 · FY2014 · AI · contact PI
Determining the functions of novel genes for influenza A and Ebola viruses$372,312
U19 · FY2014 · AI · contact PI
Transmissibility of avian influenza viruses in mammals$23,621
R01 · FY2014 · AI · contact PI
Modeling Host Responses to Understand Severe Human Virus Infections$4,107,674
U19 · FY2013 · AI · contact PI
Systems Biology Analysis of Influenza A Virus and Ebola Virus$941,909
U19 · FY2013 · AI · contact PI
Transmissibility of avian influenza viruses in mammals$603,743
R01 · FY2013 · AI · contact PI
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus$602,426
R01 · FY2013 · AI · contact PI
Determining the functions of novel genes for influenza A and Ebola viruses$500,187
U19 · FY2013 · AI · contact PI
Administrative Core$496,688
U19 · FY2013 · AI · contact PI
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity$472,039
U54 · FY2013 · AI · contact PI
Prevention and control of Ebola virus infection$306,871
U54 · FY2013 · AI · contact PI
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus$640,878
R01 · FY2012 · AI · contact PI
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity$594,748
U54 · FY2012 · AI · contact PI
Transmissibility of avian influenza viruses in mammals$575,009
R56 · FY2012 · AI · contact PI
Prevention and control of Ebola virus infection$355,808
U54 · FY2012 · AI · contact PI
A high-growth PR8 virus for pandemic vaccine production in ST6-Vero cells$220,126
R43 · FY2012 · AI
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus$655,156
R01 · FY2011 · AI · contact PI
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity$624,088
U54 · FY2011 · AI · contact PI
Nanoemulsions as novel adjuvents for influenza virus vaccines$596,673
U01 · FY2011 · AI · contact PI
Prevention and control of Ebola virus infection$593,590
U54 · FY2011 · AI · contact PI
TROPISM AND REPLICATION OF NOVEL H1N1 INFLUENZA VIRUSES$140,786
P51 · FY2011 · RR · contact PI
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus$653,029
R01 · FY2010 · AI · contact PI
Nanoemulsions as novel adjuvents for influenza virus vaccines$602,700
U01 · FY2010 · AI · contact PI
Prevention and control of Ebola virus infection$558,116
U54 · FY2010 · AI · contact PI
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity$531,398
U54 · FY2010 · AI · contact PI
Pandemic Potential of H5N1 Influenza Viruses$480,844
R01 · FY2010 · AI · contact PI
Molecular Pathogenesis of Ebolavirus Infection$446,019
R01 · FY2010 · AI · contact PI
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza Virus$656,068
R01 · FY2009 · AI · contact PI
Nanoemulsions as novel adjuvents for influenza virus vaccines$599,570
U01 · FY2009 · AI · contact PI
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity$538,495
U54 · FY2009 · AI · contact PI
Prevention and control of Ebola virus infection$533,515
U54 · FY2009 · AI · contact PI
Pandemic Potential of H5N1 Influenza Viruses$499,900
R01 · FY2009 · AI · contact PI
Pandemic Potential of H5N1 Influenza Viruses$484,020
R01 · FY2009 · AI · contact PI
Molecular Pathogenesis of Ebolavirus Infection$459,686
R01 · FY2009 · AI · contact PI
Influenza Virus Assembly$404,246
R01 · FY2009 · AI · contact PI
Nanoemulsions as novel adjuvents for influenza virus vaccines$587,319
U01 · FY2008 · AI · contact PI
Pandemic Potential of H5N1 Influenza Viruses$485,519
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of Influenza Pandemics$407,730
R01 · FY2008 · AI · contact PI
Influenza Virus Assembly$394,001
R01 · FY2008 · AI · contact PI
Prevention and Control of Ebola Virus Infection$260,080
U54 · FY2008 · AI · contact PI
Nanoemulsions as novel adjuvents for influenza virus vaccines$599,438
U01 · FY2007 · AI · contact PI
Pandemic Potential of H5N1 Influenza Viruses$491,594
R01 · FY2007 · AI · contact PI
Molecular Mechanisms of Influenza Pandemics$403,522
R01 · FY2007 · AI · contact PI
Influenza Virus Assembly$388,672
R01 · FY2007 · AI · contact PI
Molecular Basis for Ebola Virus Pathogenicity$347,491
R01 · FY2007 · AI · contact PI
Pandemic Potential of H5N1 Influenza Viruses$506,275
R01 · FY2006 · AI · contact PI
Molecular Mechanisms of Influenza Pandemics$415,176
R01 · FY2006 · AI · contact PI
Influenza Virus Assembly$394,874
R01 · FY2006 · AI · contact PI
Molecular Basis for Ebola Virus Pathogenicity$347,445
R01 · FY2006 · AI · contact PI
Molecular Mechanisms of Influenza Pandemics$546,123
R01 · FY2005 · AI
Influenza Virus Assembly$388,199
R01 · FY2005 · AI
Molecular Basis for Ebola Virus Pathogenicity$345,442
R01 · FY2005 · AI
Molecular Mechanisms of Influenza Pandemics$526,358
R01 · FY2004 · AI
Molecular Basis for Ebola Virus Pathogenicity$335,381
R01 · FY2004 · AI
INFLUENZA VIRUS ASSEMBLY$324,000
R01 · FY2004 · AI
Molecular Pathogenesis of Lassa virus infection$291,000
R21 · FY2004 · AI
INFLUENZA VIRUS ASSEMBLY$594,500
R01 · FY2003 · AI
MOLECULAR MECHANISMS OF INFLUENZA PANDEMICS$319,200
R01 · FY2003 · AI
Molecular Pathogenesis of Lassa virus infection$291,000
R21 · FY2003 · AI
Molecular Basis for Ebola Virus Pathogenicity$165,807
R01 · FY2003 · AI
INFLUENZA VIRUS ASSEMBLY$324,000
R01 · FY2002 · AI
MOLECULAR MECHANISMS OF INFLUENZA PANDEMICS$310,036
R01 · FY2002 · AI
MOLECULAR PATHOGENESIS OF EBOLA VIRUS INFECTION$250,011
R01 · FY2002 · AI
INFLUENZA VIRUS ASSEMBLY$324,000
R01 · FY2001 · AI
MOLECULAR MECHANISMS OF INFLUENZA PANDEMICS$301,138
R01 · FY2001 · AI
MOLECULAR PATHOGENESIS OF EBOLA VIRUS INFECTION$242,757
R01 · FY2001 · AI
MOLECULAR MECHANISMS OF INFLUENZA PANDEMICS$339,684
R01 · FY2000 · AI
INFLUENZA VIRUS ASSEMBLY$324,000
R01 · FY2000 · AI
MOLECULAR PATHOGENESIS OF EBOLA VIRUS INFECTION$235,716
R01 · FY2000 · AI